Connect with us

Hi, what are you looking for?

International

Covid Remedy Becoming a Disease, Nations Encountering New Challenges

Germany, France and Italy enlisted among the countries to suspend the Covid-19 vaccine from Oxford-AstraZeneca, after receiving reports of unusual blood clotting problems among a few people who recently received the shots in Norway. Denmark, Iceland, the Democratic Republic of Congo, Indonesia and the Netherlands have also suspended AstraZeneca vaccinations.

Health ministry of Germany referred to the advice of the national health regulator in its decision to suspend the vaccine, though global health officials have cautioned that millions of people have received it without any problems. However, experts around the world insist that there is no evidence of a causal link between clotting and the vaccine, with investigations from the European Medicines Agency and other regulators still underway.

On the other hand, Thailand said that it would resume distribution of the AstraZeneca vaccine on Tuesday, with Prime Minister Prayuth Chan-ocha among the first to receive it.

Europe is facing a third wave of infections, with Italy imposing strict new restrictions and France considering doing the same. Hungary’s prime minister predicted hospitals this week would be at their most overwhelmed since the start of the pandemic. The spread of coronavirus variants and slow vaccination rates are among the likely factors.

Avatar photo
Written By

Breaking News

Kapil Sharma and his team faced another setback after their show has been ended on the Netflix. It is, indeed, a sad and bad...

Entertainment

HeeramandiIn the latest chapter of entertainment discourse, the highly anticipated Netflix series “Heeramandi: The Diamond Bazaar” has triggered a wave of disappointment among Pakistani...

National

During the inauguration of a field hospital in Lahore, Punjab Chief Minister Maryam Nawaz encouraged her critics to engage in public service, suggesting that...

Economy

The transaction will be referred for an in-depth Phase 2 analysis.